CPC Central Committee and State Council: Exploring the establishment of a “white list” system for biomedical companies to import R&D items

The “Opinion” suggests that it is necessary to enhance the overall competitiveness of foreign trade, promote the optimization and upgrading of trade in goods, enhance the development vitality of trade in services, and support the innovative development of digital trade. Explore the establishment of a “white list” system for biomedical companies to import products for research and development, allowing exemptions from customs clearance forms for imported drugs. Explore the establishment of a “white list” system for imported food and drug substances to allow food substances for food purposes to clear customs according to actual use. (Xinhua News Agency)